541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Federal contract awards under NAICS code 541714 — who won, from which agency, for how much. Public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
1,611
awards
463
expiring in 12 months
10+
competing vendors
Who wins in 541714
Agencies buying under 541714
Department of Health and Human Services (1003)Department of Defense (494)Department of Veterans Affairs (51)National Aeronautics and Space Administration (24)Department of Agriculture (14)Department of Homeland Security (8)Department of the Interior (7)General Services Administration (4)Department of State (3)Department of Commerce (1)
Recent awards
DEVELOP A CARTILAGE TISSUE CONSTRUCT WITH IMMUNOMODULATORY PROPERTIES CAPABLE OF MAINTAINING HEALTHY CARTILAGE CELL FUNCTION UNDER CHALLENGING ENVIRONMENTS, SUCH AS INFLAMMATION AND ACTIVATED IMMUNE CELLS, BOTH ON EARTH AND IN SPACE.
STI LEGACY, INC. · National Aeronautics and Space Administration · $650,000 · Oct 31, 2028
STTR PHASE II - DEVELOPMENT OF AN ULTRA-LOW CONCENTRATION BIOSENSOR FOR USE IN PROTEIN SEQUENCING
PRIMARY BIOSCIENCE, INC. · Department of the Interior · $1,799,870 · Oct 1, 2026
EO 14398-BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT FOR MODERNIZING OUTCOME DATA FOR OPIOID USE DISORDER (MOD-OUD)
DIGITAL MEDICINE SOCIETY INC · Department of Health and Human Services · $948,781 · Sep 30, 2026
COUNTERING NIHILISTIC VIOLENT EXTREMIST (NVE) THREATS - UNO NCITE
UNIVERSITY OF NEBRASKA · Department of Homeland Security · $1,838,383 · Sep 30, 2026
THE OVERARCHING OBJECTIVE IS TO ESTABLISH A QUANTITATIVE IN VITRO IN VIVO EXTRAPOLATION FRAMEWORK CAPABLE OF PREDICTING THE INFLUENCE OF FORMULATION COMPOSITION, DIGESTION BEHAVIOR, CHYLOMICRON BINDING, AND PRANDIAL STATE ON DRUG BIOAVAILABILITY AND
SIMULATIONS PLUS INC · Department of Health and Human Services · $651,399 · Sep 30, 2026
EO 14398
PERSONALIS, INC. · Department of Veterans Affairs · $18,290,000 · Sep 30, 2026
TO CONDUCT AND DEFINE THE TECHNICAL AND PROGRAMMATIC REQUIREMENTS FOR A THREE-YEAR, MULTI-INSTITUTIONAL RESEARCH AND DEVELOPMENT EFFORT TO REVERSE ENGINEER, CHARACTERIZE, MANUFACTURE, AND EVALUATE PROTOTYPE LONG-ACTING POLY(LACTIC-CO-GLYCOLIC ACID)
UNIVERSITY OF TEXAS AT AUSTIN · Department of Health and Human Services · $688,145 · Sep 30, 2026
FDA BAA FY26C1CP13 3-YEAR FIRM-FIXED PRICE (FFP) CONTRACT FOR INVESTIGATING THE IMPACT OF DIASTEREOMERS AND SYNTHESIS-RELATED IMPURITIES ON THE IMMUNOGENICITY OF OLIGONUCLEOTIDES.
UNIVERSITY OF CONNECTICUT · Department of Health and Human Services · $1,173,033 · Sep 30, 2026
EO-14398-A LONG-TERM VASCULAR MPS TO ASSESS CYCLIC CARDIOVASCULAR TOXICITY OF ONCOLOGY DRUGS
BRIGHAM & WOMENS HOSPITAL INC · Department of Health and Human Services · $2,998,734 · Sep 30, 2026
ISSUANCE OF TASK ORDER FOR THE CARE, BREEDING, AND PROVISON OF SPF MACAQUES. DAP-NCAP-00000188
ALPHA GENESIS INC · Department of Health and Human Services · $8,092,003 · Sep 30, 2026
C02 SENSOR PROTOTYPE DEVELOPMENT
RED DUKE STRATEGIES LLC · Department of Veterans Affairs · $1,499,888 · Sep 30, 2026
EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP3 - ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIENCE - CORE CLINICAL OUTCOME ASSESSMENT GRANT PROGRAM
DUKE UNIVERSITY · Department of Health and Human Services · $1,456,427 · Sep 30, 2026
5-YEAR FFP CONTRACT FOR RESEARCH AND DEVELOPMENT SERVICES, BAA FY26C1AP28: MECHANISTIC EVALUATION OF ORAL PEPTIDE ABSORPTION USING ORGANOID-BASED NAMS TO SUPPORT BIOEQUIVALENCE ASSESSMENT.
UNIVERSITY OF FLORIDA · Department of Health and Human Services · $645,503 · Sep 30, 2026
MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS)
SANOFI VACCINES US INC. · Department of Health and Human Services · $6,018,839 · Sep 30, 2026
DDI CLINICAL PHARMACOLOGY STUDY
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC · Department of Health and Human Services · $1,592,481 · Sep 30, 2026
BAA FY26C3AP4: A CROSS-SPECIES IMMUNE ORGAN CHIP REFERENCE FRAMEWORK FOR REGULATORY EVALUATION OF VACCINE AND ANTIVIRAL MEDICAL COUNTERMEASURES = EO 14398
BOARD OF REGENTS OF NEVADA SYSTEM OF HIGHER EDUCATION · Department of Health and Human Services · $1,500,000 · Sep 30, 2026
3-YEAR FFP CONTRACT FOR RESEARCH AND DEVELOPMENT SERVICES, BAA FY26C1CP2, MECHANISTIC INSIGHT INTO AGGREGATION BEHAVIOR AND PREDICTIVE MODELING OF LONG-ACTING INJECTABLE NANO-SUSPENSIONS.
UNIVERSITY OF CONNECTICUT · Department of Health and Human Services · $657,981 · Sep 30, 2026
EO 14398 - INTEGRATING PAT TOOLS (E.G., RAMAN SPECTROSCOPY) WITH DIGITAL TWIN MODELING TO CLARIFY THE UNCERTAINTY IN DIRECT CQA CONTROL WITHIN CONTINUOUS FRAMEWORKS.
UNIVERSITY OF MASSACHUSETTS LOWELL · Department of Health and Human Services · $861,756 · Sep 30, 2026
THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOINJECTORS (AS A DRUG/DEVICE COMBINATION PRODUCT) TO TREAT ORGANOPHOSPHATE (OP) POISONING, INCLUDING NERVE AGENT
KALEO, INC. · Department of Health and Human Services · $96,058,494 · Sep 30, 2026
BAA CONTRACT- FY26C2AP9 ADVANCED CMC INDEX AND INTELLIGENCE PLATFORM FOR DRUG QUALITY CONTROL, SHORTAGE PREDICTION, AND STRATEGIC RESHORING
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC · Department of Health and Human Services · $634,642 · Sep 30, 2026
TO ADVANCE THE DEVELOPMENT, EVALUATION, AND PREDICTIVE MODELING OF LEVONORGESTREL INTRAUTERINE SYSTEMS (LNG-IUSS) BY INTEGRATING ACCELERATED TESTING, REAL-TIME RELEASE STUDIES, MICROSTRUCTURAL ANALYSIS, AND AI/ML-DRIVEN MODELING APPROACHES.
UNIVERSITY OF CONNECTICUT · Department of Health and Human Services · $511,219 · Sep 30, 2026
BAA FY26C1CP48: A MULTI-AGENT AI SYSTEM FOR HIGH-THROUGHPUT PBPK MODELING: PREDICTING FORMULATION EFFECT ON DRUG ABSORPTION AND HUMAN PHARMACOKINETICS
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Department of Health and Human Services · $500,000 · Sep 30, 2026
TO PROVIDE RESEARCH AND DEVELOPMENT SERVICES TO DESIGN, DEVELOP, VALIDATE, AND DELIVER AN AI-ASSISTED DIGITAL TWIN PLATFORM FOR PHARMACEUTICAL LYOPHILIZATION PROCESS DEVELOPMENT AND SCALE-UP.
UNIVERSITY OF MASSACHUSETTS LOWELL · Department of Health and Human Services · $456,721 · Sep 30, 2026
EO 14398 - RISK ASSESSMENT
SCITOVATION, LLC · Department of Health and Human Services · $337,915 · Sep 30, 2026
THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL INFECTION
PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD. · Department of Health and Human Services · $545,542 · Sep 30, 2026
Awards are history. Bids are opportunity. BidCatch scans 100+ federal, state, and local sources every night and emails the open opportunities in your trade. $0 today for 14 days (card required), then $49.99/month.
Search open bids